|
|
|
| Prokaryotic Soluble Expression and Immunogenicity Analysis of VP1 Gene of Foot-and-mouth disease virus serotypes SAT2 |
| LI Guo-Xiu1,3,*, OU Yun-Wen1,2,*, DING Yao-Zhong1, LI Qian1, DAI Jun-Fei1, LIU Lei3,**, ZHANG Jie1,** |
1 Office International Des Epizooties (OIE)/National Foot-and-Mouth Disease (FMD) Reference Laboratory/State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730046, China;
2 Animal Disease Prevention and Control Center of Kaijiang County, Dazhou 636250, China;
3 College of Veterinary Medicine, Gansu Agricultural University, Lanzhou, 730070, China |
|
|
|
|
Abstract Foot-and-mouth disease serotypes Southern African Territories 2 (SAT2-FMD) is an acute, heat, and highly contactive infectious disease caused by Foot-and-mouth disease virus serotypes Southern African Territories 2 (SAT2-FMDV). At present, global trade and mutual visits are frequent, and the risk of SAT2-FMD entering China is extremely high, which will seriously threaten the sustainable and healthy development of Chinese breading industry. This experiment was aimed to prokaryotic soluble expression and analysis the immunogenicity of VP1 gene of SAT2-FMDV (GenBank No. JX014256). The gene was amplified from the recombined plasmid pUC57-His-SUMO-SAT2-VP1 by PCR, with a product of approximately 993 bp. The identified recombined plasmid pET32a-HisSUMO-VP1 was expressed by Escherichia coli BL21 (DE3) and was induced by 1 mmol/L isopropy-β-D-thiogalactoside (IPTG). The HisSUMO-VP1 protein was purified by Ni-NTA, and the purified protein was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDA-PAGE) and Western blot. The HisSUMO-VP1 protein was used as an immunogen for immunization of Balb/C mice (Mus musculus), and the serum antibody, spleen lymphocyte proliferation and cytokine levels were detected. The results of SDA-PAGE and Western blot showed that the HisSUMO-VP1 protein with a relative molecular weight of 63 kD was highly soluble and had good reactivity. The immune experiment found that the serum antibody levels in the immunized mice vaccinated with the HisSUMO-VP1 fusion protein group was significantly higher than those in the HisSUMO protein vaccinated group and the mock group (P<0.001), and the mice spleen lymphocytes had a significant lymphocyte proliferation response (P<0.001). The levels of IFN-γ and IL-2 were significantly higher than those in the PBS group (P<0.05). The HisSUMO-VP1 protein with excellent immunogenicity is solublely expressed in E. coli, providing data support for the diagnosis and vaccine development of SAT2-FMDV.
|
|
Received: 06 March 2020
|
|
|
|
Corresponding Authors:
** liuleigs@163.com; zhangjie03@caas.cn
|
| About author:: * The authors who contribute equally |
|
|
|
[1] 高闪电, 常惠芸, 独军政, 等. 2010. SAT2型口蹄疫病毒南非地区分离株结构蛋白VP1及其C端的表达、纯化和反应原性分析[J]. 细胞与分子免疫学杂志, 26(07): 631-634.
(Gao S D, Chang H Y, Du J Z, et al.2010. Prokaryotic expression, protein purification and reactivity analysis of the VP1 and its C term inus of a south african isolate of FMDV serotype SAT2[J]. Chinese Journal of Cellular and Molecular Immunology, 26(7): 631-634.)
[2] 侯立婷, 陈瑾, 乔绪稳, 等. 2017. 猪O型口蹄疫病毒细菌样颗粒疫苗的制备与免疫原性鉴定[J]. 生物工程学报, 33(02): 217-227.
(Hou L T, Chen J, Qiao X W, et al.2017. Design and immunogenicity evaluation for the bacteria-like particle vaccine against swine Type O foot-and-mouth disease virus[J]. Chinese Journal of Biotechnology, 33(02): 217-227.)
[3] 李迎秋, 王旭东, 龚宇, 等. 2016. SUMO化修饰调控T细胞免疫突触形成和T细胞活化[J].中国科学基金, 30(04): 315-319.
(Li Y Q, Wang X D, Gong Y, et al.2016. TCR-induced sumoylation of the kinase PKC-controls T cells ynapse organization and T cell activation[J]. Bulletin of National Natural Science Foundation of China, 30(04): 315-319.)
[4] 刘汉平. 2019. 猪O型口蹄疫病毒样颗粒的构建及鉴定[J].中国畜牧兽医, 46(11): 3350-3357.
(Liu H P.2019. Construction and identification of swine O-type foot-and-mouth disease virus-like particles[J]. China Animal Husbandry & Veterinary Medicine, 46(11): 3350-3357.)
[5] 汪肖肖, 孙普, 王省, 等. 2019.口蹄疫表位疫苗的研究进展[J].中国兽医科学, 49(04): 499-505.
(Wang X X, Sun P, Wang S, et al.2019. Progress of foot-and-mouth disease epitope vaccine[J]. Chinese Veterinary Science, 49(04): 499-505.)
[6] 韦平, 秦爱建. 2008. 重要动物病毒分子生物学[M]. 北京: 科学出版社.
(Wei P, Qing A J.2008. Molecular Biology of Important Animal Viruses[M]. Science Press. Beijing, China)
[7] 赵宝磊, 刘运超, 陈玉梅, 等. 2017. O型口蹄疫病毒VP0和VP1蛋白的可溶性表达与反应原性分析[J]. 河南农业科学, 46(02): 105-110.
(Zhao B L, Liu Y C, Chen Y M, et al.2017. Soluble expression and immunogenicity analysis of FMDV VP0 and VP1 protein[J]. Journal of Henan Agricultural Sciences, 46(02): 105-110.)
[8] Bai X W, Li P H, Bao H F, et al.2011. Evolution and molecular epidemiology of Foot-and-mouth disease virus in China[J]. Chinese Science Bulletin, 56(21): 2191-2201.
[9] Bastos A D S, Anderson E C, Bengis R G, et al.2003. Molecular epidemiology of SAT3-type foot-and-mouth disease[J]. Virus Genes, 27(3): 283-290.
[10] Cao Y, Sun P, Fu Y, et al.2010. Formation of virus-like particles from O-type Foot-and-mouth disease virus in insect cells using codon-optimized synthetic genes[J]. Biotechnology Letters, 32(9): 1223-1229.
[11] Despras E, Sittewelle M, Pouvelle C, et al.2016. Rad18-dependent SUMO ylation of human specialized DNA polymerase eta is required to prevent under-replicated DNA[J]. Nature Communications, 11(7): 1-15.
[12] Du P, Liu R H, Sun S Q, et al.2019. Biomineralization improves the thermostability of Foot-and-mouth disease virus-like particles and the protective immune response induced[J]. Nanoscale, 47(11): 22748-22761.
[13] Jamal S M, Belsham G J.2018. Molecular epidemiology, evolution and phylogeny of Foot-and-mouth disease virus[J]. Infection Genetics and Evolution, 59(4): 84-98.
[14] Kardjadj M.2018. History of foot-and-mouth disease in north African countries[J]. Veterinaria Italiana, 54(1): 1-12.
[15] Lycett S, Tanya V N, Hall M.et al.2019. The evolution and phylodynamics of serotype A and SAT2 Foot-and-mouth disease virus in endemic regions of Africa[J]. Scientific Reports, 9(1): 5614-5640.
[16] Mahapatra M, Parida S.2018. Foot and mouth disease vaccine strain selection: Current approaches and future perspectives[J]. Expert Review of Vaccines, 17: 577-591.
[17] Morioka K, Urayama K, Wada A, et al.2020. Development and evaluation of silver amplification immunochromatography kit for Foot-and-mouth disease virus antigen detection[J]. Journal of Virological Methods, 275(1): 1-7.
[18] Nandi S P, Rahman M Z, Momtaz S, et al.2015. Emergence and distribution of Foot-and-mouth disease virus serotype A and O in Bangladesh[J]. Transboundary and Emerging Diseases, 62(3): 328-331.
[19] Orton R J, Wright C F, King D P, et al.2020. Estimating viral bottleneck sizes for FMDV transmission within and between hosts and implications for the rate of viral evolution[J]. Interface Focus, 10(1): 1-10.
[20] Prejit, Pratheesh P T, Nimisha S,et al.2019. Expression and purification of an immunogenic SUMO-OmpC fusion protein of Salmonella typhimurium in Escherichia coli[J]. Biologicals, 62(11): 22-26.
[21] Raman N, Weir E, Muller S.2016. The AAA ATP-ase MDN1 acts as a SUMO-targeted regulator in mammalian pre-ribosome remodeling[J]. Molecular Cell, 64(3): 607-615.
[22] Ryu H Y, Wilson N R, Mehta S, et al.2016. Loss of the SUMO protease Ulp2 triggers a specific multichromosome aneuploidy[J]. Genes & Development, 30(16): 1881-1894.
[23] Tekleghiorghis T, Moormann R J M, Weerdmeester K, et al.2014. Serological evidence indicates that Foot-and-mouth disease virus serotype O, C and SAT1 are most dominant in Eritrea[J]. Transboundary and Emerging Diseases, 61(6): 83-88.
[24] Willems T, De Vleeschauwer A, Perez-Filgueira M, et al.2020. FMD vaccine matching: Inter laboratory study for improved understanding of r1values[J]. Journal of Virological Methods, 276(10): 1-7.
[25] Yuan H, Li P, Ma X, et al.2017. The pH stability of Foot-and-mouth disease virus[J].Virology Journal, 14(1): 233-237. |
|
|
|
